Irish woundcare company resumes float plans:
This article was originally published in Clinica
Alltracel Pharmaceuticals, an Irish company which first announced that it planned a market flotation in 1997, has said that it now plans to push for a complete stock market listing by the end of this year, following a private placement in the next few weeks. The Sallynoggin, County Dublin-based company has proprietary blood coagulation technology, known as m-doc, developed by Czech researchers.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.